|
2024
|
Invention
|
Methods of treating cancer with anti-pd-1 agents. The disclosure provides a method of treating ca... |
|
|
Invention
|
Novel use of an inhibior of the a poly-adp ribose polymerase (parp) in the treatment of cancer. T... |
|
|
Invention
|
Methods of treating cancer with anti-tim-3 antibodies.
The present disclosure provides methods o... |
|
2023
|
Invention
|
Combination therapies for treating cancer.
The present invention provides methods of treatment f... |
|
|
Invention
|
Methods of treating cancer with anti-pd-1-antibodies. The disclosure provides a method of treatin... |
|
|
Invention
|
Methods of treating non-small cell lung cancer with anti-pd-1-antibodies. The disclosure provides... |
|
|
Invention
|
Methods of treating ovarian cancer.
The present invention provides methods of administering a PA... |
|
|
Invention
|
Biocatalysts and methods thereof. The present disclosure relates to transaminase biocatalysts and... |
|
|
Invention
|
Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3).
Provided herein a... |
|
|
Invention
|
Niraparib formulations.
The present invention relates to pharmaceutical tablet compositions comp... |
|
|
Invention
|
Niraparib compositions.
The present invention relates to compositions comprising the compound ni... |
|
|
Invention
|
Combination therapy comprising a mat2a inhibitor and a parp inhibitor. Provided herein is a combi... |
|
|
Invention
|
Use of niraparib for the treatment of brain cancer.
The present invention provides methods of ad... |
|
|
Invention
|
Use of niraparib for the treatment of brain cancer. The present invention provides methods of adm... |
|
|
Invention
|
Antibody agents directed against lymphocyte activation gene-3 (lag-3) and uses thereof.
The disc... |
|
2022
|
Invention
|
Methods of treating cancer with anti-pd-1 antibodies. The present invention provides methods of a... |
|
|
Invention
|
Combination treatment of cancer with a parp inhibitor and a lipophilic statin.
The present inven... |
|
|
Invention
|
Combination treatment of cancer with a parp inhibitor and a lipophilic statin. The present invent... |
|
2021
|
Invention
|
Methods of manufacturing of niraparib. Disclosed herein are methods and processes of preparing ni... |
|
|
Invention
|
Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3). Provided herein ar... |
|
|
Invention
|
Antibodies directed against programmed death-1 (pd-1).
The disclosure provides antibody agents t... |
|
|
Invention
|
Niraparib compositions. The present invention relates to compositions comprising the compound nir... |
|
2020
|
Invention
|
Biopharmaceutical compositions and related methods.
The invention described herein provides comp... |
|
|
Invention
|
Biopharmaceutical compositions and related methods. The invention described herein provides compo... |
|
|
Invention
|
Niraparib formulations.
The present invention relates to pharmaceutical capsule compositions com... |
|
|
Invention
|
Methods of treating ovarian, fallopian tube and peritoneal cancer. The present invention provides... |
|
|
Invention
|
Methods for characterizing and treating a cancer type using cancer images.
Described herein are ... |
|
|
Invention
|
Methods for characterizing and treating a cancer type using cancer images. Described herein are m... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer. |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of cancer. |
|
|
Invention
|
Niraparib salts. Novel salts of niraparib are provided. Also provided are pharmaceutical composit... |
|
|
Invention
|
Crystalline forms of niraparib freebase.
Crystalline niraparib freebase is provided. Also provid... |
|
|
Invention
|
Crystalline forms of niraparib freebase. Crystalline niraparib freebase is provided. Also provide... |
|
|
Invention
|
Methods of treating cancer.
This invention relates to new methods for treating cancer, including... |
|
|
Invention
|
Methods of treating cancer. This invention relates to new methods for treating cancer, including ... |
|
|
P/S
|
Biological preparations for the treatment of cancer. |
|
|
P/S
|
Biological preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer and cancer-treatment-based sym... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer |
|
|
Invention
|
Pediatric niraparib formulations and pediatric treatment methods.
The present invention relates ... |
|
2018
|
Invention
|
Methods of treating cancer.
The present invention provides methods of treatment of cancer patien... |
|
|
Invention
|
Process for preparing intermediate of anti-tumor drug niraparib and intermediate thereof. Disclos... |
|
|
Invention
|
Combination therapies and uses thereof. The present disclosure relates to combination therapies c... |
|
|
Invention
|
Combination therapies for treating cancer with niraparib and pd-1 inhibitors. The present inventi... |
|
|
Invention
|
Niraparib formulations. The present invention relates to pharmaceutical tablet compositions compr... |
|
|
Invention
|
Combination therapies for treating cancer. The present invention provides methods of treatment fo... |
|
|
Invention
|
Methods of treating cancer with anti-tim-3 antibodies. The present disclosure provides methods of... |
|
2017
|
Invention
|
Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3).
The disclosure pr... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of
cancer. |
|
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological related diseases and disorders, and ... |
|
2016
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparatio... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer. |
